BOSTON, July 09, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical stage biopharmaceutical company focused on developing transformative therapies targeting functional cures for immunological ...
FreeCast, a next-generation media, entertainment, and technology platform, has announced the pricing of a $23.7 million private placement of common stock with new institutional investors and existing ...
JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...
A 500-page UNESCO 2026 report says Trinidad and Tobago’s Secondary Entrance Assessment (SEA) continues to determine children’s futures too early, sorting them by class and leaving ...
Watertown biotech Remix Therapeutics secures $100 million in private placement financing and will merge with Passage Bio to go public on Nasdaq under ticker RMTX.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results